New Research Available

The Investment Trust Research team at Winterflood Securities has produced a 'Fund Insight' research report about Odyssean Investment Trust, providing an overview of the fund's strategy and performance to help investors navigate the market.

This report is free to read for UK investors and can be accessed here: https://www.winterflood.com/fundinsight

Important Information

Winterflood Securities Ltd ("Winterflood") is authorised and regulated by the Financial Conduct Authority (FRN 141455).

The company covered in this report has appointed and paid Winterflood to write this research. Winterflood has structured its business to manage any conflicts of interest. Further details regarding conflicts, risks, and other investor educational information can be found in the Glossary & Disclaimer section of the report.

This report contains general information and does not constitute and shall not be implied to constitute an investment recommendation, a personal recommendation or advice, or an offer/solicitation to buy or sell or take any action in relation to any investments mentioned herein. Winterflood cannot provide advice relating to legal, tax, financial matters and as such you should seek independent professional advice before making any investment decision. Winterflood accepts no liability whatsoever in connection with any decision that you make in connection with this report. This report is based on information obtained from sources believed to be reliable, but which have not been independently verified and are not guaranteed as being accurate.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments.

This research report is not intended for distribution to, or use by, any individuals or entities based in the US or any jurisdictions where there are restrictions for such activity under local law or regulation which would subject Winterflood to regulatory authorisations.

UK 100